Overview

HTX-011 in Spinal Surgery

Status:
Not yet recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
This is a Phase 2, multicenter study in subjects undergoing an open 2-level, lumbar laminectomy without fusion.
Phase:
Phase 2
Details
Lead Sponsor:
Heron Therapeutics
Treatments:
Bupivacaine
Epinephrine